| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | 0.075 | 0.5 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |